Immune modulatory effects of Idelalisib in stromal cells of chronic lymphocytic leukemia-Reference-Cited by-同舟云学术

Immune modulatory effects of Idelalisib in stromal cells of chronic lymphocytic leukemia

Published:2021-05-17 Issue:11 Volume:62 Page:2679-2689
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Handl Sarah¹,von Heydebrand Franziska¹,Voelkl Simon¹,Oostendorp Robert A. J.²,Wilke Jochen³,Kremer Anita N.¹,Mackensen Andreas¹,Lutzny-Geier Gloria¹^ORCID

Affiliation:

1. Department of Internal Medicine 5, Hematology and Oncology, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany

2. Clinic and Polyclinic for Internal Medicine III: Hematology and Oncology, Klinikum rechts der Isar, Technical University Munich, Munich, Germany

3. Practice for Oncology and Hematology, Fürth, Germany

Funder

GILEAD

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2021.1927019

Reference27 articles.

1. Chronic Lymphocytic Leukemia

2. Chronic Lymphocytic Leukemic B Cells But Not Normal B Cells Are Rescued From Apoptosis by Contact With Normal Bone Marrow Stromal Cells

3. Bi-directional activation between mesenchymal stem cells and CLL B-cells: implication for CLL disease progression

4. Protein Kinase C-β-Dependent Activation of NF-κB in Stromal Cells Is Indispensable for the Survival of Chronic Lymphocytic Leukemia B Cells In Vivo

5. Environment-mediated drug resistance: a major contributor to minimal residual disease

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protein Kinase C (PKC) Isozymes as Diagnostic and Prognostic Biomarkers and Therapeutic Targets for Cancer;Cancers;2022-11-03

2. PI3 kinase isoform p110δ is more important than p110α in KIT signaling in hematopoietic cells;BIOCELL;2022